Research programme: macrophage colony stimulating factor receptor 1 kinase inhibitors - BCI Pharma
Latest Information Update: 03 Jul 2024
At a glance
- Originator BCI Pharma
- Developer BCI Pharma; Mithra Pharmaceuticals
- Class Analgesics; Anti-inflammatories; Antineoplastics; Antirheumatics; Small molecules
- Mechanism of Action Macrophage colony-stimulating factor receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Endometriosis; Gynaecological cancer; Inflammation; Pain
- Research Rheumatoid arthritis